drugset / Trial / NCT01228357
Predict Antidepressant Responsiveness Using Pharmacogenomics
Non-randomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to determine whether genetic information associated with individual depressive symptoms.
Timeline
- Start
- 2003-02
- Primary completion
- 2018-12
- Completion
- 2018-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluoxetine | Small molecule | — | — |
| Comparator | Milnacipran | Other / unclassified | — | — |
| Comparator | Mirtazapine | Other / unclassified | — | — |
| Comparator | Nortriptyline | Small molecule | — | — |
| Subject | Paroxetine | Small molecule | — | — |
| Subject | Sertraline | Small molecule | — | — |
| Comparator | Venlafaxine | Small molecule | — | — |